Who
Antal Rohit Desai
Director
Company insider
Files Form 4 as: Director and 10% owner, PROCEPT BioRobotics; 10% owner, Apollo Endosurgery.
In numbers
- Trades disclosed
- 123
- Buys
- 4
- Sells
- 15
- Bought
- $32.0M
- Sold
- $36.1M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 14 Sep 2021
- Last trade
- 9 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 10 Jun 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Code A | —3,315 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | PRCT PROCEPT BioRoboticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,853 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | PRCT PROCEPT BioRoboticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,853 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Code A | —3,315 at $0.00 | filing |
| 9 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $1.0M43,581 at $24.08 | filing |
| 9 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $1.3M53,818 at $24.91 | filing |
| 9 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $33K1,300 at $25.42 | filing |
| 9 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $1.0M43,581 at $24.08 | filing |
| 9 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $1.3M53,818 at $24.91 | filing |
| 9 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $33K1,300 at $25.42 | filing |
| 6 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $2.5M106,554 at $23.33 | filing |
| 6 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $1.3M53,763 at $24.10 | filing |
| 6 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $2.5M106,554 at $23.33 | filing |
| 6 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $1.3M53,763 at $24.10 | filing |
| 5 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $3.6M142,498 at $25.44 | filing |
| 5 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $654K24,748 at $26.41 | filing |
| 5 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $3.6M142,498 at $25.44 | filing |
| 5 Mar 2026filed 9 Mar 2026 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Bought | $654K24,748 at $26.41 | filing |
| 14 Aug 2025filed 15 Aug 2025 | PRCT PROCEPT BioRoboticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —26,749 at $0.00 | filing |
| 14 Aug 2025filed 15 Aug 2025 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Code M | $36K26,749 at $1.33 | filing |
News
No headline names them, or the companies they trade most, lately.